Objective To study the safety and efficacy of dexmedetomidine hydrochloride combined with midazolam in fiberoptic bronchoscopy in children. Methods A total of 118 children who planned to undergo fiberoptic bronchoscopy from September 2018 to February 2021 were enrolled. They were divided into a control group (n=60) and an observation group (n=58) using a random number table. The observation group received intravenous pumping of dexmedetomidine hydrochloride (2 μg/mL) at 1 μg/kg and then intravenous injection of midazolam at 0.05 mg/kg, followed by dexmedetomidine hydrochloride pumped intravenously at 0.5-0.7 μg/(kg·h) 10 minutes later to maintain anesthesia. The control group was given intravenous pumping of propofol at 2 mg/kg and then intravenous injection of midazolam at 0.05 mg/kg, followed by propofol pumped intravenously at 4-6 mg/(kg·h) 10 minutes later to maintain anesthesia. Fiberoptic bronchoscopy was performed after the children were unconscious. Heart rate (HR), respiratory rate, blood oxygen saturation, and mean arterial pressure (MAP) were recorded before inserting the bronchoscope (T0), at the time of inserting the bronchoscope (T1), when the bronchoscope reached the glottis (T2), when the bronchoscope reached the carina (T3), and when the bronchoscope entered the bronchus (T4). The intraoperative peak airway pressure (Ppeak), examination time, degree of sedation, extent of amnesia, incidence of adverse reactions, postoperative awakening time, and postoperative agitation score were also recorded. Results Compared with the control group, the observation group had significantly decreased MAP at T1 to T4 and HR at T1 to T3 (P<0.05). Compared with that at T0, MAP was significantly increased at T1 to T4 in the control group and at T3 in the observation group (P<0.05). HR was significantly higher at T1 to T3 than at T0 (P<0.05). Compared with the control group, the observation group showed significantly lower intraoperative Ppeak value, incidence of intraoperative adverse reactions, and postoperative agitation score, significantly shorter examination time, and better effects of amnesia and anesthesia (P<0.05). There was no significant difference in the degree of intraoperative sedation and postoperative awakening time between the two groups (P>0.05). Conclusions Dexmedetomidine hydrochloride combined with midazolam is a safe and effective way to administer general anesthesia for fiberoptic bronchoscopy in children, which can ensure stable vital signs during examination, reduce intraoperative adverse reactions and postoperative agitation, shorten examination time, and increase amnesic effect.
Key words
Fiberoptic bronchoscopy /
Dexmedetomidine hydrochloride /
Midazolam /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 匡荣, 赵乐怿, 吴家麟, 等. 右美托咪定在小儿纤维支气管镜检查及肺泡灌洗术中的应用[J]. 实用临床医药杂志, 2020, 24(10): 88-91. DOI: 10.7619/jcmp.202010022.
2 冯斌, 刘巍, 叶茂. 右美托咪定复合静脉全身麻醉在小儿纤支镜检查治疗中的应用[J]. 重庆医科大学学报, 2019, 44(6): 778-782. DOI: 10.13406/j.cnki.cyxb.002136.
3 叶玉萍, 淮诗媚, 刘涌, 等. 术前布地奈德雾化吸入用于1~3岁幼儿无痛纤维支气管镜检查的临床观察[J]. 中华实用儿科临床杂志, 2018, 33(3): 229-231. DOI: 10.3760/cma.j.issn.2095-428X.2018.03.017.
4 程太平. 右美托咪定+瑞芬太尼用于小儿纤维支气管镜检查的效果[J]. 西南国防医药, 2018, 28(5): 466-468. DOI: 10.3969/j.issn.1004-0188.2018.05.027.
5 宗小川. 盐酸右美托咪定与咪达唑仑在小儿术前镇静中的应用对比[J]. 临床研究, 2020, 28(7): 59-60.
6 上官扬琴, 吴论, 彭学强, 等. 右美托咪定复合咪达唑仑在B超引导下小儿臂丛神经阻滞麻醉中的应用[J]. 山东医药, 2020, 60(2): 59-61. DOI: 10.3969/j.issn.1002-266X.2020.02.017.
7 高义, 戴朋其, 石磊, 等. 右美托咪定混合罗哌卡因用于小儿尿道下裂修复术阴部神经阻滞的改良效果[J]. 中华麻醉学杂志, 2020, 40(9): 1105-1108. DOI: 10.3760/cma.j.cn131073.20200515.00917.
8 冉隆青, 伍孟军, 刘怀清. 右美托咪啶复合七氟烷麻醉辅助利多卡因超声雾化用于婴幼儿无痛纤支镜检查的安全性和有效性观察[J]. 中国临床医生杂志, 2016, 44(3): 41-43. DOI: 10.3969/j.issn.2095-8552.2016.03.014.
9 高燕春, 侯冠峰, 谢言虎, 等. 二氧化碳气腹对不同年龄组小儿脑氧饱和度和术后躁动的影响[J]. 中国现代医学杂志, 2020, 30(5): 119-123. DOI: 10.3969/j.issn.1005-8982.2020.05.023.
10 盛俊峰, 刘金环. 咪达唑仑联合利多卡因雾化吸入在小儿支气管镜检查中的临床效果观察[J]. 重庆医学, 2015, 44(7): 961-963. DOI: 10.3969/j.issn.1671-8348.2015.07.037.
11 卓海珍, 何海燕. 喉罩全身麻醉用于小儿纤维支气管镜检查中的效果及安全性[J]. 临床肺科杂志, 2020, 25(3): 431-433. DOI: 10.3969/j.issn.1009-6663.2020.03.024.
12 黄文锋. 右美托咪定复合小剂量丙泊酚用于无痛纤维支气管镜检查的有效性及安全性[J]. 山西医药杂志, 2019, 48(2): 152-154. DOI: 10.3969/j.issn.0253-9926.2019.02.006.
13 徐保芹, 王洁, 张超, 等. 右美托咪定对妇科腹腔镜手术患者血浆胃动素及术后不良反应的影响[J]. 医学研究生学报, 2019, 32(5): 526-531. DOI: 10.16571/j.cnki.1008-8199.2019.05.015.
14 Yin WC, Wang CY, Peng Y, et al. Dexmedetomidine alleviates H2O2-induced oxidative stress and cell necroptosis through activating of α2-adrenoceptor in H9C2 cells[J]. Mol Biol Rep, 2020, 47(5): 3629-3639. PMID: 32342432. DOI: 10.1007/s11033-020-05456-w.
15 Li ZB, Li GC, Qin J. Dexmedetomidine attenuates lung injury in toxic shock rats by inhibiting inflammation and autophagy[J]. Arch Med Res, 2021, 52(3): 277-283. PMID: 33248818. DOI: 10.1016/j.arcmed.2020.11.001.
16 Wu ZF, He L, Lai Y, et al. Observation of the sedative effect of dexmedetomidine combined with midazolam nasal drops before a pediatric craniocerebral MRI[J]. J Craniofac Surg, 2020, 31(6): 1796-1799. PMID: 32877157. DOI: 10.1097/SCS.0000000000006657.
17 van Groen BD, Krekels EHJ, Mooij MG, et al. The oral bioavailability and metabolism of midazolam in stable critically ill children: a pharmacokinetic microtracing study[J]. Clin Pharmacol Ther, 2021, 109(1): 140-149. PMID: 32403162. PMCID: PMC7818442. DOI: 10.1002/cpt.1890.
18 龙焱, 张成成, 谈诚, 等. 右美托咪定滴鼻与咪达唑仑口服用于小儿术前用药效果的比较: meta分析[J]. 中华麻醉学杂志, 2020, 40(2): 195-198. DOI: 10.3760/cma.j.issn.0254-1416.2020.02.017.
19 贾苗, 吴小乐, 范从海, 等. 不同剂量右美托咪定与咪达唑仑滴鼻在小儿腺样体切除术中的应用效果[J]. 广西医科大学学报, 2019, 36(11): 1801-1805. DOI: 10.16190/j.cnki.45-1211/r.2019.11.021.
20 戴必照, 刘金东, 谢文静, 等. 盐酸右美托咪定复合酮咯酸氨丁三醇在小儿斜视手术中的应用[J]. 中国妇幼保健, 2020, 35(24): 4889-4892. DOI: 10.19829/j.zgfybj.issn.1001-4411.2020.24.080.
PDF(578 KB)
